Evidence map›Paper›PMID 39106475›Full record

ArticleACS infectious diseases2024

In Vitro and In Vivo Studies on a Mononuclear Ruthenium Complex Reveals It is a Highly Effective, Fast-Acting, Broad-Spectrum Antimicrobial in Physiologically Relevant Conditions.

Adam M Varney, Kirsty L Smitten, Hannah M Southam, Simon D Fairbanks, Craig C Robertson, Jim A Thomas, Samantha McLean

Abstract read
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Novel ruthenium(II) polypyridyl complexes conjugated with bis-dipicolylamine as antibacterial photosensitisers.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adam M VarneySchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, U.K.ORCID 0000-0002-5943-161X
Kirsty L SmittenDepartment of Chemistry, University of Sheffield, Brook Hill, Sheffield S3 7HF, U.K.
Hannah M SouthamSchool of Bioscience, The University of Sheffield, Western Bank, Sheffield S10 2TN, U.K.
Simon D FairbanksDepartment of Chemistry, University of Sheffield, Brook Hill, Sheffield S3 7HF, U.K.
Craig C RobertsonDepartment of Chemistry, University of Sheffield, Brook Hill, Sheffield S3 7HF, U.K.
Jim A ThomasDepartment of Chemistry, University of Sheffield, Brook Hill, Sheffield S3 7HF, U.K.ORCID 0000-0002-8662-7917
Samantha McLeanSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, U.K.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The crystal structure of a previously reported antimicrobial Ru

Indexed as

Anti-Bacterial AgentsMicrobial Sensitivity TestsRutheniumAnimalsCoordination ComplexesHumansMothsStaphylococcal InfectionsStaphylococcus aureusUrinary Tract InfectionsAnti-Bacterial AgentsCoordination ComplexesRutheniumAMRcombinatorial therapyESKAPEGalleriaruthenium

Identifiers

PMID39106475
PMCPMC11406528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.